Generate a tailored SOP for Dr. Michael Macklin. Improve your application with a focused, well-structured draft.
Michael Macklin is an Assistant Professor in the Biological Sciences Division at the University of Chicago, specializing in Rheumatology. He leads the multidisciplinary Scleroderma Program, which integrates expertise from various specialties, including Pulmonary, Cardiology, Gastroenterology, Plastic Surgery, and Dermatology, to provide comprehensive care for individuals diagnosed with systemic sclerosis (scleroderma). His research emphasizes improving the diagnosis and treatment of systemic sclerosis, focusing on clinical trials and innovative therapies such as CAR-T cell treatment. Furthermore, he is an active member of the multidisciplinary interstitial lung disease (ILD) group at the University of Chicago, overseeing a specialized rheumatology-pulmonary clinic designed for patients with ILD resulting from autoimmune diseases. The ILD Program is renowned internationally for its collaborative clinical research and offers clinical trials for these conditions. Additionally, Macklin is involved in medical education, mentoring learners in various stages of medical training, and he has specific interests in IgG4-related disease, contributing as a member of the multidisciplinary IgG4 Clinical Consortium.
University of Chicago • Chicago, IL
Specializes in Rheumatology, leading the multidisciplinary Scleroderma Program.
Department of Philosophy